Company Overview
Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, rosette cataract, and congenital glaucoma. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.
Why Investors Should Care
Generates a return on equity of 25.2%, reflecting efficient use of shareholder capital.
Operating margin of 18.0% supports profitability.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Trailing 12 Months Year-on-year growth — revenue +20.2%, earnings -1.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | 20.20% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -1.20% |
Stock Price Performance
| 1 Year: | +6.19% |
| 6 Months: | - |
| 3 Months: | - |
| 1 Month: | +1.67% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- RSI (14)55.25 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Strong return on equity of 25.2%.
- Generates positive free cash flow.
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for DRAGARWQ
NEPHROPLUS Stock Price and Chart — NSE:NEPHROPLUS - TradingView
<a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBBa3cxeXJOY1QtbVIxUWpRYjA5R1dzYVVPeDdVWXQycEQ5N1ZGOVNaajBxbjZKUUVXaU83M21WZ1hyQktiLTh6ajltT0tXOHNZbWxldzVNMWRKZ0lzYVBlcA?oc=5" target="_blank">NEPHROPLUS Stock Price and Chart — NS…
DRAGARWQ — Frequently Asked Questions
What is the current share price of Dr. Agarwal's Eye Hospital Limited (DRAGARWQ)?
As of 2026-07-16 05:21 IST, Dr. Agarwal's Eye Hospital Limited (DRAGARWQ) trades at ₹5,084.00 on NSE. Its 52-week range is ₹4,787.85 to ₹5,183.80.
What is the return on equity (ROE) of DRAGARWQ?
DRAGARWQ has a return on equity (ROE) of 25.22%.
Is DRAGARWQ a good stock to buy?
This page provides a data-driven analysis of Dr. Agarwal's Eye Hospital Limited (DRAGARWQ), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.